- Home
- TDF vs DERM Comparison
TDF vs DERM Comparison
Compare TDF & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TDF
- DERM
- Stock Information
- Founded
- TDF 1994
- DERM 2014
- Country
- TDF Singapore
- DERM United States
- Employees
- TDF N/A
- DERM N/A
- Industry
- TDF Finance/Investors Services
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- TDF Finance
- DERM Health Care
- Exchange
- TDF Nasdaq
- DERM Nasdaq
- Market Cap
- TDF 244.7M
- DERM 213.6M
- IPO Year
- TDF N/A
- DERM 2021
- Fundamental
- Price
- TDF $11.49
- DERM $7.92
- Analyst Decision
- TDF
- DERM Strong Buy
- Analyst Count
- TDF 0
- DERM 3
- Target Price
- TDF N/A
- DERM $12.67
- AVG Volume (30 Days)
- TDF 79.2K
- DERM 255.0K
- Earning Date
- TDF 01-01-0001
- DERM 11-12-2025
- Dividend Yield
- TDF N/A
- DERM N/A
- EPS Growth
- TDF N/A
- DERM N/A
- EPS
- TDF N/A
- DERM N/A
- Revenue
- TDF N/A
- DERM $59,399,000.00
- Revenue This Year
- TDF N/A
- DERM $26.16
- Revenue Next Year
- TDF N/A
- DERM $45.27
- P/E Ratio
- TDF N/A
- DERM N/A
- Revenue Growth
- TDF N/A
- DERM 2.82
- 52 Week Low
- TDF $7.15
- DERM $3.54
- 52 Week High
- TDF $10.62
- DERM $9.40
- Technical
- Relative Strength Index (RSI)
- TDF 47.34
- DERM 46.18
- Support Level
- TDF $11.34
- DERM $8.71
- Resistance Level
- TDF $11.86
- DERM $9.40
- Average True Range (ATR)
- TDF 0.29
- DERM 0.54
- MACD
- TDF -0.00
- DERM -0.08
- Stochastic Oscillator
- TDF 54.94
- DERM 22.93
About TDF Templeton Dragon Fund Inc.
Templeton Dragon Fund Inc is a closed-end management investment company. The fund seeks long-term capital appreciation by investing majority of its total assets in equity securities of China companies. It invests in various sectors such as gas & consumable fuels, auto components, banks, beverages, communications equipment, healthcare equipment & supplies, restaurants & leisure, household durables and many others.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.